T2 Biosystems (TTOO) received an Intention to Grant a European Patent for EP Appl. No. 17205422.3, titled: METHODS FOR AMPLIFYING AND DETECTING PATHOGEN NUCLEIC ACID IN A WHOLE BLOOD SAMPLE - Patent E
Tweet
Share
E-mailGet Alerts TTOO Hot Sheet
Join SI Premium – FREE
T2 Biosystems (NASDAQ: TTOO) received an Intention to Grant a European Patent for EP Appl. No. 17205422.3, titled: METHODS FOR AMPLIFYING AND DETECTING PATHOGEN NUCLEIC ACID IN A WHOLE BLOOD SAMPLE - Patent Eagle (LINK)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Atlassian (TEAM) Announces Resignation of Co-CEO Scott Farquhar
- Rollins (ROL) Appoints Louise S. Sams to its Board
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
